| Technology Name | Briefcase | Lead Researcher |
|---|---|---|
Keywords
Nanoparticles, Neuropeptides, Intranasal delivery
Current development stage
TRL4 - POC & Safety of candidate drug formulation is demonstrated in defined animal model
Highlights
Emulsification in aqueous media is not effective ... More | Domb Abraham | |
Additional information will be provided upon request
More | Domb Abraham | |
Additional information will be provided upon request
More | Avraham Yosefa | |
Drug-eluting stents (DES) are widely used in intravascular intervention.
The current technology is based on crystallization of drug onto stent surface (with no- polymer) Coating process is resulting in high yield coatings that constantly release ... More | Domb Abraham | |
Additional information will be provided upon request
More | Domb Abraham | |
Categories:
Life Science & Biotechnology
Technology Keywords:
Formulation, drug delivery, increased bioavailability
Development Stage:
POC in animalOur Innovation
The PNL formulation composed of GRAS materials enabling ... More | Domb Abraham | |
Category
Life Sciences and Bio Technology
Keywords
Nanoparticles, Neuropeptides, Intranasal delivery
Current development stage
TRL4 - POC & Safety of candidate drug formulation is demonstrated in defined animal modelHighlights ... More | Domb Abraham | |
Company Name
Aferrix
Company Founders
Prof. Zvi Ioav Cabantchik,
Current CEO
Yael Furman, Ms.C., MBA, CEO
About the Company
Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of ... More | Cabantchik Ioav | |
Categories:
Life Science & Biotechnology
Technology Keywords:
Formulation, drug delivery, increased bioavailability
Development Stage:
POC in Human
Highlights
The P-gp efflux and oxidative Phase I metabolism are major predicaments ... More | Domb Abraham | |
Additional information will be provided upon request
More | Domb Abraham |